Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Current State of Treatment and Future Directions in Cutaneous Malignant Melanoma
Madison Ernst, Alessio Giubellino
Biomedicines (2022) Vol. 10, Iss. 4, pp. 822-822
Open Access | Times Cited: 46

Showing 1-25 of 46 citing articles:

Melanoma Treatments and Mortality Rate Trends in the US, 1975 to 2019
Navkirat Kahlon, Sishir Doddi, Rame Yousif, et al.
JAMA Network Open (2022) Vol. 5, Iss. 12, pp. e2245269-e2245269
Open Access | Times Cited: 50
A Review of Current and Pipeline Drugs for Treatment of Melanoma
Nicole Natarelli, Soo Aleman, Isabella Mark, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 2, pp. 214-214
Open Access | Times Cited: 15
FDUM-Net: An enhanced FPN and U-Net architecture for skin lesion segmentation
H. Sharen, Malathy Jawahar, L. Jani Anbarasi, et al.
Biomedical Signal Processing and Control (2024) Vol. 91, pp. 106037-106037
Closed Access | Times Cited: 9
Exosome-based immunotherapy as an innovative therapeutic approach in melanoma
Shabnam Babaei, Manouchehr Fadaee, Hajar Abbasi‐Kenarsari, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 6
The signaling function of IDO1 incites the malignant progression of mouse B16 melanoma
Elena Orecchini, M.F. Belladonna, MT Pallotta, et al.
OncoImmunology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 14
Discovery of a small molecule that inhibits Bcl-3-mediated cyclin D1 expression in melanoma cells
Karunakar Saamarthy, Kristofer Ahlqvist, Renée Daams, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 4
Challenges and opportunities of predicting overall survival benefit from improvements to recurrence-free survival in stage II/III melanoma: a correlation meta-analysis
LP Leung, John M. Kirkwood, S. Srinivasan, et al.
Immuno-Oncology Technology (2025) Vol. 25, pp. 101042-101042
Open Access
An optimised Bcl‐3 inhibitor for melanoma treatment
Karunakar Saamarthy, Renée Daams, Wondossen Sime, et al.
British Journal of Pharmacology (2025)
Open Access
Clinical Approaches for the Management of Skin Cancer: A Review of Current Progress in Diagnosis, Treatment, and Prognosis for Patients with Melanoma
Christopher M. O Connor, Quinton L. Carr, Alisa Sweazy, et al.
Cancers (2025) Vol. 17, Iss. 4, pp. 707-707
Open Access
Development of a Decision Model to Estimate the Outcomes of Treatment Sequences in Advanced Melanoma
Saskia de Groot, Hedwig M. Blommestein, B Leeneman, et al.
Medical Decision Making (2025)
Open Access
Arginase-II promotes melanoma and lung cancer cell growth by regulating Sirt3-mtROS axis
Yang Yang, Andrea Brenna, Duilio Michele Potenza, et al.
Frontiers in Cell and Developmental Biology (2025) Vol. 13
Open Access
Molecular interactions between fibrinogen and 6-methoxydihydrosanguinarine and their modulation of anticancer activity in melanoma A375 cells
Chenchen Zuo, Xulei Jiang, Jianian Hu, et al.
International Journal of Biological Macromolecules (2025), pp. 142170-142170
Closed Access
Targeted melanoma therapy: High-efficiency siRNA delivery with R8-PEI dissolvable microneedles
Yaozhen He, S.-P. Chen, Wen‐Dong Song, et al.
International Journal of Pharmaceutics (2025), pp. 125516-125516
Closed Access
Quercetin as a Potential Therapeutic Agent for Malignant Melanoma—A Review of Current Evidence and Future Directions
Teodora Hoinoiu, Victor Dumitraşcu, D. S. S. Pit, et al.
Medicina (2025) Vol. 61, Iss. 4, pp. 656-656
Open Access
Cell Death Modalities in Therapy of Melanoma
Meng Wang, Jiahui Zhao, Ming Tang, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 8, pp. 3475-3475
Open Access
A Case of Retrorectal Melanoma Presenting With Bleeding Per Rectum
Saurabh Dubey, Memoona Khan, Nasir Gondal
Cureus (2025)
Open Access
New Potential Agents for Malignant Melanoma Treatment—Most Recent Studies 2020–2022
Paweł Kozyra, Danuta Krasowska, Monika Pitucha
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 11, pp. 6084-6084
Open Access | Times Cited: 16
Unique CLR expression patterns on circulating and tumor-infiltrating DC subsets correlated with clinical outcome in melanoma patients
Eleonora Sosa Cuevas, Jenny Valladeau‐Guilemond, Stéphane Mouret, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 16
Analysis and prediction of 5-year survival in patients with cutaneous melanoma: a model-based period analysis
Suzheng Zheng, Hai Yu, Xinkai Zheng, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 7
Advances in Microbiome‐Based Therapeutics for Dermatological Disorders: Current Insights and Future Directions
Tushar Madaan, Kyla Doan, Alexandra R. Hartman, et al.
Experimental Dermatology (2024) Vol. 33, Iss. 12
Closed Access | Times Cited: 2
Dermokine mutations contribute to epithelial-mesenchymal transition and advanced melanoma through ERK/MAPK pathways
Wenqiong Ma, Zexiu Wu, Mazaher Maghsoudloo, et al.
PLoS ONE (2023) Vol. 18, Iss. 7, pp. e0285806-e0285806
Open Access | Times Cited: 6
Impact of anesthesia choice in cutaneous melanoma surgery
Matthew G.K. Benesch, Joseph J. Skitzki
Melanoma Research (2023)
Closed Access | Times Cited: 4
Distinct patterns of proteostasis network gene expression are associated with different prognoses in melanoma patients
Rachel Wellman, Daniel H. Jacobson, Maria Secrier, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Programmable Release of Chemotherapeutics from Ferrocene‐Based Injectable Hydrogels Slows Melanoma Growth
R Rothe, Yong Xu, Johanna Wodtke, et al.
Advanced Healthcare Materials (2024) Vol. 13, Iss. 27
Open Access | Times Cited: 1
Impact of Genomic Mutation on Melanoma Immune Microenvironment and IFN-1 Pathway-Driven Therapeutic Responses
Fátima María Mentucci, Elisa Ayelén Romero Nuñez, Agustina Ercole, et al.
Cancers (2024) Vol. 16, Iss. 14, pp. 2568-2568
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top